Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems.
D000367:Age Factors; D000632:Aminopyrine / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001565:Benzoates / Q000378:metabolism; D001580:Benzopyrenes / Q000378:metabolism; D001711:Biotransformation; D003580:Cytochromes / Q000378:metabolism; D003677:Deficiency Diseases / Q000378:metabolism*; D006591:Hexobarbital / Q000378:metabolism / Q000494:pharmacology; D007037:Hypothyroidism / Q000139:chemically induced / Q000378:metabolism; D007454:Iodides / Q000378:metabolism; D007501:Iron / Q000378:metabolism; D051379:Mice; D008862:Microsomes, Liver / Q000032:analysis / Q000201:enzymology* / Q000378:metabolism*; D009596:Nitrophenols / Q000378:metabolism; D011441:Propylthiouracil; D012256:Riboflavin / Q000378:metabolism; D012257:Riboflavin Deficiency / Q000378:metabolism; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000814:Aniline Compounds; D001565:Benzoates; D001580:Benzopyrenes; D003580:Cytochromes; D007454:Iodides; D009596:Nitrophenols; D000632:Aminopyrine; D011441:Propylthiouracil; D006591:Hexobarbital; D007501:Iron; D012256:Riboflavin